 |
| Crispr Genomic Cure Market |
CRISPR therapies help rectify malfunctioning genes that cause genetic disorders such as sickle cell anemia, cystic fibrosis and various cancers. The technology allows modification of genes with high precision and efficiency compared to previous techniques.
The global
Crispr Genomic Cure Market is estimated to be valued at US$ 1.84 Bn in 2023 and is expected to exhibit a CAGR of 11% over the forecast period
2023 to 2030, as highlighted in a new report published by Coherent Market
Insights.
Market key Trends:
Rising disease burden has accelerated the growth of Crispr Genomic Cure Market.
With increasing incidences of various genetic disorders, there has been growing
demand for efficient treatment options. CRISPR technology provides potential
cure by precisely editing the malfunctioning genes responsible for diseases.
This has boosted research activities focused on developing Crispr based
therapies. Several clinical trials are underway to evaluate efficacy and safety
of Crispr treatments. Potential success of ongoing studies can further fuel the
market growth.
Segment Analysis
The CRISPR Genomic Cure Market is dominated by the CRISPR gene editing sub
segment which holds around 60% of the total market share. CRISPR gene editing
is gaining high prominence owing to its precise and simple method of editing
genomes. It allows scientists to simply cut and paste desirable traits into
DNA, which has led to its widespread adoption over other complex gene editing
techniques.
Key Takeaways
The global CRISPR
Genomic Cure Market growth is expected to witness high growth. The
global Crispr Genomic Cure Market is estimated to be valued at US$ 1.84 Bn in
2023 and is expected to exhibit a CAGR of 11% over the forecast period 2023 to
2030.
Regional analysis related content
comprises:
North America is currently the largest market for Crispr Genomic Cures in terms
of revenue. This is attributed to high adoption rates for innovative genomic
technologies along with presence of prominent market participants in the US.
However, Asia Pacific is poised to offer most lucrative growth opportunities
during the forecast period. Countries such as China and India are witnessing
significant investments to promote genomics research from both public and
private sectors. Additionally, the rising geriatric population base susceptible
to chronic conditions in Asia Pacific will further aid the market expansion.
Key players related content comprises:
Key players operating in the Crispr Genomic Cure Market are Marriott
International, Hilton Worldwide Holdings Inc., InterContinental Hotels Group
PLC, and Four Seasons Hotels and Resorts. Marriott International dominates the
overall market owing to its robust global presence and diversified brand
portfolio catering to all hotel segments.
For more insights, read- https://www.ukwebwire.com/crispr-genomic-cure-market-trends-size-and-share-analysis/
For more details on the report, Read- https://dailynewsmotion.weebly.com/report-blog/luxury-travel-market-is-estimated-to-witness-high-growth-owing-to-increased-adventurism
0 Comments